# Evaluating the Role of Both PSMA and 64Cu-PET/CT Total Body in Patients With Locally Relapsed Prostate Cancer

> **NCT04703543** · NA · COMPLETED · sponsor: **Regina Elena Cancer Institute** · enrollment: 50 (actual)

## Conditions studied

- Prostate Neoplasms

## Interventions

- **DEVICE:** Pilot evaluation study on use PSMA and Cu-PET/CT

## Key facts

- **NCT ID:** NCT04703543
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-22
- **Primary completion:** 2020-06-09
- **Final completion:** 2020-06-09
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04703543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04703543, "Evaluating the Role of Both PSMA and 64Cu-PET/CT Total Body in Patients With Locally Relapsed Prostate Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04703543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*